Retatrutide — lab test, October 2026
COA P70-442 matches Uzorak's public record. So this test doesn't rest on our review alone — the lab confirms it too.
P70-442Test results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 60 mg · Lab measured 66.9 mg
112% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 16.7 mg using the measured mass, against 15 mg on the label — 12% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | P70-442 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Uzorak's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Uzorak on October 5, 2026. Reported purity: 98.49%. Net content: 66.9 mg against 60 mg labeled (112% of label). Tested content exceeds the labeled amount by 12%. Batch RT60-20260929-01. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion